0001209191-18-007830.txt : 20180206 0001209191-18-007830.hdr.sgml : 20180206 20180206161118 ACCESSION NUMBER: 0001209191-18-007830 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180202 FILED AS OF DATE: 20180206 DATE AS OF CHANGE: 20180206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lydon Nicholas CENTRAL INDEX KEY: 0001639935 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37985 FILM NUMBER: 18577732 MAIL ADDRESS: STREET 1: BLUEPRINT MEDICINES CORP. STREET 2: 215 FIRST STREET, SUITE 340/350 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANAPTYSBIO INC CENTRAL INDEX KEY: 0001370053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203828755 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10421 PACIFIC CENTER COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-362-6295 MAIL ADDRESS: STREET 1: 10421 PACIFIC CENTER COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: ANAPTYS BIOSCIENCES INC DATE OF NAME CHANGE: 20060724 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-02 0 0001370053 ANAPTYSBIO INC ANAB 0001639935 Lydon Nicholas C/O ANAPTYSBIO, INC. 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 1 0 0 0 Director Stock Option (right to buy) 104.81 2018-02-02 4 A 0 6000 0.00 A 2028-02-01 Common Stock 6000 6000 D The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. /s/ Nicholas B. Lydon by Dominic Piscitelli, Attorney-in-Fact 2018-02-06